Skip to content
StockMarketAgent
Direct answer
EMR trades against a final fair-value range of $88.69-$155.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs. Fair value range: low $88.7, high $156, with mid-point at $122.
Stock analysis

EMR fair value $89–$156

By StockMarketAgent.AI team· supervised by
분석일: 2026-05-13다음 업데이트: 2026-08-13Methodology v2.5Review: automatedArchetype: Mature compounder
View archive
주가
$137.28
▼ -15.07 (-10.98%)
공정 가치
$122
$89–$156
등급
비중 축소
confidence 87/100
상승 여력
-11.0%
upside to fair value
안전 마진
$103.88
MoS level · 15%
시가총액
$76.9B
P/E fwd 19.2
영어 원본으로 대체KO
번역하는 동안 영어 원본을 표시 중
이 리포트는 아직 번역되지 않았습니다. 번역 대기열이 따라잡으면 몇 분 후에 새로고침하세요.

§1 개요

  • Composite fair value $122 with high case $156.
  • Implied downside of 11.0% to fair value.
  • Moat 9/10 · confidence 87/100 · Mature compounder.
  • Currently screens above fair value, so patience matters more than entry speed.
Fair value
$122
Margin of safety
-12.3%
Confidence
87/100
Moat
9/10

Educational analysis only — not financial advice. Always do your own due diligence.

$137.28Price
Low $88.69
Mid $122.21
High $155.92

EMR trades against a final fair-value range of $88.69-$155.92, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.

  • High switching costs associated with
    High switching costs associated with mission-critical process automation platforms like DeltaV.
  • Sticky, high-margin software and service
    Sticky, high-margin software and service recurring revenue base.
  • Bull thesis
    Reduce-side internal valuation cross-checks ($164.87) aggressively prices in perfect execution of the M&A synergy playbook and permanent retention of 24.2% outlier margins.

§2 베어 케이스

A synchronized global industrial recession combined with delays in clean energy CAPEXCapital expendituresCash spent on acquiring or upgrading property, plant, and equipment. Splits into maintenance capex (sustaining current capacity) and growth capex (expanding capacity). stalls near-term automation spending. The newly acquired software segments fail to offset hardware cyclicality, causing margins to revert to the 16% historical peer average.

이 논제가 무너지는 경로

M&A Value Destruction

20%· Medium

Failure to extract synergies from recent software acquisitions causes ROIC to stagnate below WACC, driven by the $18B goodwill burden.

FV impact
$88.69 (Implies ~35% downside)

Automation CAPEX Freeze

25%· Medium

Macroeconomic weakness and deferred conventional energy projects significantly halt process automation spending across key markets.

FV impact
Significant multiple compression to 15x legacy industrial norms.

Margin Reversion

30%· Medium

Current 24.2% operating margins prove unsustainable and revert to the 16% historical industry norm amidst competitive pricing pressures.

FV impact
Downside to the Multi-Stage Moat Fade midpoint of $77.53.
모니터링할 조기 경보 신호
지표현재트리거 임계값
Consecutive quarters of declining software and services recurring revenue.MonitorDeterioration versus the report thesis
Operating margins compressing below the 21% normalized assumption.MonitorDeterioration versus the report thesis
Unadjusted ROIC falling further below current 6.9% due to asset bloat.MonitorDeterioration versus the report thesis
Significant downward revisions in forward private EPS estimate reference.MonitorDeterioration versus the report thesis
Management pausing or cutting the dividend/buyback program to preserve cash.MonitorDeterioration versus the report thesis

§3 재무 이력

손익계산서 — 최근 6기
항목T−0T−1T−2T−3CAGR
기간2022-09-302023-09-302024-09-302025-09-30Trend
매출$13.80B$15.17B$17.49B$18.02B+9.3%
매출총이익$6.31B$7.43B$8.89B$9.52B+14.7%
영업이익$2.36B$2.76B$2.67B$3.53B+14.4%
순이익$3.23B$13.22B$1.97B$2.29B-10.8%
EPS (희석)$5.41$22.88$3.43$4.04-9.3%
EBITDA$3.50B$4.22B$4.03B$4.84B+11.4%
R&D
판관비$3.61B$4.19B$5.14B$5.10B+12.2%

품질 점수

OCF / 순이익
1.35×
>1은 이익의 질이 높음을 의미
회계 품질 게이트
Fail
섹터 조정 게이트
ROIC
7.7%
투하자본수익률
섹션 3

Numbers analysis

현금 흐름

Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.

자본 배분

Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.

개인 구독자 — §4부터11개 섹션 더

전체 분석 읽기 — 11개 섹션 더.

Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.

모든 커버 종목에 대한 전체 보고서
24개월 등급 아카이브
관심 목록 브리핑 + 등급 변경 알림
모든 언어로 PDF + DOCX 내보내기
무료 체험 시작
언제든지 취소 가능.
MARGINS FAQ

EMR margins questions

  1. EMR (EMR)'s margin set covers gross margin, operating margin, net margin, and free-cash-flow margin. The five-year trajectory is plotted so the reader can separate cyclical noise from secular trend.
FAQ

EMR — frequently asked questions

  1. Based on our latest analysis, EMR screens modestly overvalued. The current price is $137 versus a composite fair-value midpoint of $122 (range $88.7–$156), which implies roughly 11.0% downside to the midpoint.
Related coverage

Names readers of EMR also follow

Same archetype: mature-compounder